Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Sarcoma × Troglitazone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Pancreatic Neoplasms 1 Liposarcoma 1 Diabetes Mellitus, Type 2 1

Interventions

Doxorubicin 80 Ifosfamide 54 Radiotherapy 43 Filgrastim 41 Gemcitabine 37 Cyclophosphamide 33 Etoposide 26 Vincristine 24 Cisplatin 24 Docetaxel 23 pazopanib 21 Trabectedin 19 Carboplatin 17 pembrolizumab 15 Peripheral Blood Stem Cell Transplantation 14 eribulin 12 Mesna 12 Melphalan 12 Sorafenib 11 Sirolimus 11 Irinotecan 11 Granulocyte Colony-Stimulating Factor 11 Bevacizumab 11 Topotecan 10 Paclitaxel 10 Imatinib Mesylate 10 Chemotherapy, Adjuvant 10 pegfilgrastim 9 Temozolomide 9 Surgical Procedures, Operative 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003058 2017-02-13

Troglitazone in Treating Patients With Liposarcoma

Dana-Farber Cancer Institute

Phase 2 Completed

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡